Healthcare ETFs Dominate State Street's Top 5 Performers in June-July 2026
State Street's top five performing ETFs from June 16 to July 16, 2026, were all in the healthcare sector, with the SPDR S&P Pharmaceuticals ETF (XPH) leading at 11.69%. Other top performers included biotechnology, healthcare services, insurance, and healthcare equipment ETFs.
State Street's top five exchange-traded funds over the one-month period spanning June 16 to July 16, 2026, were all tied to the healthcare industry, led by the SPDR S&P Pharmaceuticals ETF (XPH) which surged 11.69%.
The top-performing fund, XPH, delivers targeted exposure to the pharmaceutical industry. As of July 15, 2026, it had attracted over $160 million in net year-to-date inflows.
The second-best performer was the SPDR S&P Biotech ETF (XBI), gaining 11.54% over the period. It provides targeted access to biotech companies. The SPDR S&P Health Care Services ETF (XHS) captured a 10.78% return, focusing on healthcare distributors, services, facilities, and managed care. The SPDR S&P Insurance ETF (KIE) rose 9.12%, investing in a variety of insurance companies, while the SPDR S&P Health Care Equipment ETF (XHE) gained 8.72%, offering exposure to healthcare supplies and equipment.
The strong showing across these healthcare subsectors highlights the sector’s recent momentum and investor interest.